Last reviewed: July 6, 2026 Last updated: July 6, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
People with obesity who received the weight-loss drug Zepbound had fewer obstructive sleep apnea events, or episodes of stopped breathing during sleep
A study published in August 2025 found that lean muscle mass loss via a mouse model was less than previous studies had reported, and also found that a good portion of the And research presented at the European Congress on Obesity (ECO 2025) reported that adults taking GLP-1 drugs were able to retain muscle while losing weight by strength training and eating enough protein
Te puede interesar: Alertan sobre aumento en Mxico de frmacos falsificados para perder peso
These effects matter for anyone using weight loss medications, since unintended weight loss and poor intake can complicate treatment goals and require prompt attention